Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 12174
TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459699(CHEMBL4215206 | US12006283, Example 10)
Affinity DataIC50: 600nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459674(CHEMBL4218959 | US12006283, Example 9)
Affinity DataIC50: 1.43E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459669(CHEMBL4212667 | US12006283, Example 7)
Affinity DataIC50: 1.85E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459698(CHEMBL4214799 | US12006283, Example 13)
Affinity DataIC50: 2.06E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM684581(US12006283, Example 4)
Affinity DataIC50: 2.59E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459675(CHEMBL4212353 | US12006283, Example 11)
Affinity DataIC50: 2.61E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459675(CHEMBL4212353 | US12006283, Example 11)
Affinity DataIC50: 2.82E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459691(CHEMBL4215663 | US12006283, Example 16)
Affinity DataIC50: 5.28E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459665(CHEMBL4202804 | US12006283, Example 15)
Affinity DataIC50: 6.52E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459672(CHEMBL4208298 | US12006283, Example 12)
Affinity DataIC50: 6.85E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459671(CHEMBL4203146 | US12006283, Example 14)
Affinity DataIC50: 7.35E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459693(CHEMBL4215953 | US12006283, Example 8)
Affinity DataIC50: 8.74E+3nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM684580(US12006283, Example 3)
Affinity DataIC50: 1.17E+4nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM50459676(CHEMBL4216129 | US12006283, Example 5)
Affinity DataIC50: 1.50E+4nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM684578(US12006283, Example 1)
Affinity DataIC50: 1.50E+4nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent

TargetHypoxia-inducible factor 1-alpha(Human)
Seoul National University

US Patent
LigandPNGBDBM684579(US12006283, Example 2)
Affinity DataIC50: 1.50E+4nMAssay Description:The experiment was performed in order to evaluate inhibitory activity against angiogenesis of the compounds.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/21/2024
Entry Details
US Patent